Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
On the dealmaking front, J&J acquired Halda Therapeutics in a $3.05 billion deal that includes Haldas Riptac cell-death platform and its lead candidate HLD-0915, an oral small-molecule therapy targeting metastatic castration-resistant prostate cancer (mCRPC), along with additional RIPTAC-based programs for other solid tumors
Glutathione 500mg 60 Capsules
PMID 26507459
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors
Este impulso para reducir los precios de los medicamentos surge en un contexto en el que Novo Nordisk y Eli Lilly han desarrollado un mercado creciente de frmacos para bajar de peso en los ltimos aos
3 A refresher on the SELECT trial As a refresher, the SELECT trial represented the first efforts to specifically investigate cardiovascular (CV) endpoints with GLP-1 receptor agonist medications
US$ 24.21
US$ 29.46
US$ 20.57
US$ 25.96
US$ 26.94
US$ 27.99
US$ 26.31
